Answers are grounded in this paper and cite their sources.
The main focus of this review is to discuss recent advances in nanoparticle-based multi-drug delivery platforms towards combination therapy.
No takes yet. Share an insight, caveat, or question.
Suresh Gadde (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: